567-Patient Study Confirms LMWH Safety in Pregnancy
Flora Peyvandi, former President of ISTH, recently shared an insightful post on X:
”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study.”
Read the full article here.
An article ”The Risk of Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with Anticoagulants: An International Multi-Database Cohort Study”, published by Camille Simard et al. in the Journal of Thrombosis and Haemostasis, sheds light on the safety use of low-molecular-weight heparin (LMWH) in pregnancy complicated by acute venous throembolism.
This multinational (Germany;Quebec) cohort study of 567 pregnant women with VTE treated with LMWH provided new data on bleeding risk during pregnancy.
The findings suggest that LMWH type and dosing frequency may not significantly impact bleeding risk, though further research is needed to refine anticoagulation strategies for optimizing maternal outcomes.
More on scientific advancements in the field of thrombosis featured in Hemostasis Today.
-
Mar 6, 2026, 15:43Kristy Ainslie: Breaking Down the Discovery and FDA Approval of Drug Carriers
-
Mar 6, 2026, 15:18Claudio Laudani: Efficacy and Safety of Colchicine for Secondary Prevention in Coronary Artery Disease
-
Mar 6, 2026, 15:09Chris Simon: Persona PLUS Receives FDA Clearance for Patent‑Protected Plasma Apheresis
-
Mar 6, 2026, 14:56Women’s Health at the Center of the 2025–2027 Global Public Affairs Agenda – ISTH
-
Mar 6, 2026, 14:44Haroun Gajraj: A Must-Have Atlas for Venous Duplex and Phlebology
-
Mar 6, 2026, 14:35Selma Turkovic: Announcing the New Date for the WBIT Webinar
-
Mar 6, 2026, 14:33Caitlin Raymond: Why Transfusion Medicine Should Be Looped in Early in Transfusion Reactions
-
Mar 6, 2026, 14:28Peter Kouides: Why Raising the Ferritin Cutoff in Women Matters
-
Mar 6, 2026, 12:45Gajendra Singh Sandhu: Essential Brain Health Tips to Prevent Stroke